{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:04:29Z","timestamp":1780639469755,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,10]]},"DOI":"10.7759\/cureus.43288","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T17:31:03Z","timestamp":1691688663000},"source":"Crossref","is-referenced-by-count":6,"title":["Eruptive Xanthomas Precipitated by Severe Hypertriglyceridemia From Diabetes and Alcohol Use"],"prefix":"10.7759","author":[{"given":"Nicholas R","family":"Munoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibuike C","family":"Agwuegbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Gauhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3109","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha V","year":"2020","unstructured":"Simha V. Management of hypertriglyceridemia. BMJ. 2020, 371:m3109. 10.1136\/bmj.m3109","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm030676","article-title":"Eruptive xanthomas associated with hypertriglyceridemia and new-onset diabetes mellitus","volume":"350","author":"Nayak KR","year":"2004","unstructured":"Nayak KR, Daly RG. Eruptive xanthomas associated with hypertriglyceridemia and new-onset diabetes mellitus. N Engl J Med. 2004, 350:1235. 10.1056\/NEJMicm030676","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund L","year":"2012","unstructured":"Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012, 97:2969-89. 10.1210\/jc.2011-3213","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.122.318445","article-title":"Genetic testing for hypertriglyceridemia in academic lipid clinics: implications for precision medicine: brief report","volume":"42","author":"Deshotels MR","year":"2022","unstructured":"Deshotels MR, Hadley TD, Roth M, et al.. Genetic testing for hypertriglyceridemia in academic lipid clinics: implications for precision medicine: brief report. Arterioscler Thromb Vasc Biol. 2022, 42:1461-7. 10.1161\/ATVBAHA.122.318445","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106436","article-title":"Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study","volume":"49","author":"Parker F","year":"1970","unstructured":"Parker F, Bagdade JD, Odland GF, Bierman EL. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest. 1970, 49:2172-87. 10.1172\/JCI106436","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01484.x","article-title":"Pathogenesis, detection and treatment of Achilles tendon xanthomas","volume":"35","author":"Tsouli SG","year":"2005","unstructured":"Tsouli SG, Kiortsis DN, Argyropoulou MI, Mikhailidis DP, Elisaf MS. Pathogenesis, detection and treatment of Achilles tendon xanthomas. Eur J Clin Invest. 2005, 35:236-44. 10.1111\/j.1365-2362.2005.01484.x","journal-title":"Eur J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0504a16","article-title":"Diffuse normolipemic plane xanthoma associated with monoclonal gammopathy","volume":"5","author":"Cohen YK","year":"2015","unstructured":"Cohen YK, Elpern DJ. Diffuse normolipemic plane xanthoma associated with monoclonal gammopathy. Dermatol Pract Concept. 2015, 5:65-7. 10.5826\/dpc.0504a16","journal-title":"Dermatol Pract Concept"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(71)90134-4","article-title":"Verruciform xanthoma","volume":"31","author":"Shafer WG","year":"1971","unstructured":"Shafer WG. Verruciform xanthoma. Oral Surg Oral Med Oral Pathol. 1971, 31:784-9. 10.1016\/0030-4220(71)90134-4","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.10.004","article-title":"Chylomicronemia and the chylomicronemia syndrome: a practical approach to management","volume":"121","author":"Leaf DA","year":"2008","unstructured":"Leaf DA. Chylomicronemia and the chylomicronemia syndrome: a practical approach to management. Am J Med. 2008, 121:10-2. 10.1016\/j.amjmed.2007.10.004","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-10-157","article-title":"Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study","volume":"10","author":"Sandhu S","year":"2011","unstructured":"Sandhu S, Al-Sarraf A, Taraboanta C, Frohlich J, Francis GA. Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study. Lipids Health Dis. 2011, 10:157. 10.1186\/1476-511X-10-157","journal-title":"Lipids Health Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(16)30179-1","article-title":"Secondary causes of hyperlipidemia","volume":"78","author":"Stone NJ","year":"1994","unstructured":"Stone NJ. Secondary causes of hyperlipidemia. Med Clin North Am. 1994, 78:117-41. 10.1016\/s0025-7125(16)30179-1","journal-title":"Med Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-021-00962-z","article-title":"Clinical management of hypertriglyceridemia in the prevention of cardiovascular disease and pancreatitis","volume":"23","author":"Hernandez P","year":"2021","unstructured":"Hernandez P, Passi N, Modarressi T, et al.. Clinical management of hypertriglyceridemia in the prevention of cardiovascular disease and pancreatitis. Curr Atheroscler Rep. 2021, 23:72. 10.1007\/s11883-021-00962-z","journal-title":"Curr Atheroscler Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt DL","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, et al.. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019, 380:11-22. 10.1056\/NEJMoa1812792","journal-title":"N Engl J Med"},{"key":"ref15","article-title":"Management of hypertriglyceridemia","volume":"75","author":"Oh RC","year":"2007","unstructured":"Oh RC, Lanier JB. Management of hypertriglyceridemia. Am Fam Physician. 2007, 75:1365-71.","journal-title":"Am Fam Physician"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00616","article-title":"Hypertriglyceridemia: causes, significance, and approaches to therapy","volume":"11","author":"Santos-Baez LS","year":"2020","unstructured":"Santos-Baez LS, Ginsberg HN. Hypertriglyceridemia: causes, significance, and approaches to therapy. Front Endocrinol (Lausanne). 2020, 11:616. 10.3389\/fendo.2020.00616","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4721357","article-title":"Management of hypertriglyceridemia induced acute pancreatitis","volume":"2018","author":"Garg R","year":"2018","unstructured":"Garg R, Rustagi T. Management of hypertriglyceridemia induced acute pancreatitis. Biomed Res Int. 2018, 2018:4721357. 10.1155\/2018\/4721357","journal-title":"Biomed Res Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2009.142","article-title":"Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report","volume":"9","author":"Jain D","year":"2009","unstructured":"Jain D, Zimmerschied J. Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report. ScientificWorldJournal. 2009, 9:1230-2. 10.1100\/tsw.2009.142","journal-title":"ScientificWorldJournal"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102748","article-title":"Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study","volume":"9","author":"Gubensek J","year":"2014","unstructured":"Gubensek J, Buturovic-Ponikvar J, Romozi K, Ponikvar R. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study. PLoS One. 2014, 9:e102748. 10.1371\/journal.pone.0102748","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.2009.00810.x","article-title":"Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study","volume":"33","author":"Stefanutti C","year":"2009","unstructured":"Stefanutti C, Di Giacomo S, Vivenzio A, et al.. Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study. Artif Organs. 2009, 33:1096-102. 10.1111\/j.1525-1594.2009.00810.x","journal-title":"Artif Organs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/173535-eruptive-xanthomas-precipitated-by-severe-hypertriglyceridemia-from-diabetes-and-alcohol-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:20Z","timestamp":1707509060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/173535-eruptive-xanthomas-precipitated-by-severe-hypertriglyceridemia-from-diabetes-and-alcohol-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.43288","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}